---
title: Da Vinci Project Poised for Accelerated Growth in Second Year
description: The Da Vinci Project made huge strides in 2018 and is poised to drive standards for the exchange of information critical to patient care in &lt; 2 years.
image: https://blog.pocp.com/hubfs/Imported_Blog_Media/Da-Vinci-Less-Than-Two-Years-Graphic-1024x482.jpg
---

[![logo](https://blog.pocp.com/hs-fs/hubfs/logo/logo.jpg?width=250&height=77&name=logo.jpg "logo")](https://www.pocp.com/)

<https://www.pocp.com/the-pocp-story/>

# Accelerating client's success

# using Health IT and

# business process solutions...

[Learn More](https://www.pocp.com/the-pocp-story/)

<https://www.pocp.com/regulatory-resource-center/>

# Simplifying

# regulatory

## compliance...

[Learn More](https://www.pocp.com/regulatory-resource-center/)

<https://www.pocp.com/our-client/>

# Creating value in today's

# healthcare ecosystem...

[Learn More](https://www.pocp.com/our-client/)

- Consulting 
    - [Strategy & Market Intelligence](https://www.pocp.com/strategy-market-intelligence/)
    - [Education & Research](https://www.pocp.com/education-research/)
    - [Value-Based Care Interoperability Roadmap](https://info.pocp.com/en-us/value-based-care-interoperability-strategy-and-roadmap)
    - [Multi-stakeholder Collaboratives, Program Design and Management](https://www.pocp.com/multi-stakeholder-initiatives_program-design_management)
    - [EHR Training Programs](https://www.pocp.com/ehr-training-programs/)
- [Life Sciences](https://www.pocp.com/life-sciences)
- [Regulatory Resource Center](https://www.pocp.com/regulatory-resource-center)
- About Us 
    - [The POCP Story](https://www.pocp.com/the-pocp-story/)
    - [Our Clients](https://www.pocp.com/our-client/) 
          - [Health & IT Vendors](https://www.pocp.com/our-client/health-it-vendors/)
          - [Payers & PBMS](https://www.pocp.com/our-client/payers-pbms/)
          - [Accountable Care](https://www.pocp.com/our-client/accountable-care/)
          - [Health Information Exchange](https://www.pocp.com/resource-library/health-information-exchange/)
    - [Our Team](https://www.pocp.com/our-team/)
    - [Government Contracting](https://info.pocp.com/gsa)
    - [Press](https://www.pocp.com/press/)
    - [Calendar](https://info.pocp.com/en-us/events)
    - [Careers at POCP](https://www.pocp.com/the-pocp-story/careers-at-pocp/)
- Insights 
    - [Articles and Industry Comments](https://www.pocp.com/articles/)
    - [Blog](https://blog.pocp.com/blog/)
    - [Newsletters HIT Perspectives](https://www.pocp.com/insight/newsletters-2/)
    - [Newsletters Biopharma](https://www.pocp.com/newsletters-biopharma/)
    - [POCP Industry Reports](https://www.pocp.com/industry-reports) 
          - [POCP Industry Reports](https://www.pocp.com/industry-reports)
          - [ePrior Authorization’s Real Benefits: Reducing Frictional Costs and Speeding Time to Therapy](https://www.pocp.com/downloads/ePAReport)
          - [Real-Time Pharmacy Benefit Check Report](https://www.pocp.com/pocp-industry-reports/real-time-pharmacy-benefit-check-report/)
          - [Fighting the Opioid Epidemic at the State- and Rx-Level Report](https://www.pocp.com/downloads/fighting-opioid-epidemic-at-rx-level-report)
          - [ePrescribing State Law On-Demand](https://www.pocp.com/downloads/eprescribing-state-law-on-demand/)
          - [State Law Review](https://www.pocp.com/statelawreview/)
          - [Navigator](https://www.pocp.com/navigator/)
    - [Podcasts](https://info.pocp.com/en-us/the-dish-on-health-it-podcast)
    - [Presentations and Webinars](https://www.pocp.com/presentations/)
    - [Resource Library](https://www.pocp.com/resource-library/)
    - [White Papers, Webinars and Case Studies](https://www.pocp.com/white-papers-webinars-and-case-studies-2/)
    - [Our video channel](https://www.pocp.com/our-video-channel)
- [Contact](https://www.pocp.com/contact/)

- Consulting 
    - [Strategy & Market Intelligence](https://www.pocp.com/strategy-market-intelligence/)
    - [Education & Research](https://www.pocp.com/education-research/)
    - [Value-Based Care Interoperability Roadmap](https://info.pocp.com/en-us/value-based-care-interoperability-strategy-and-roadmap)
    - [Multi-stakeholder Collaboratives, Program Design and Management](https://www.pocp.com/multi-stakeholder-initiatives_program-design_management)
    - [EHR Training Programs](https://www.pocp.com/ehr-training-programs/)
- [Life Sciences](https://www.pocp.com/life-sciences)
- [Regulatory Resource Center](https://www.pocp.com/regulatory-resource-center)
- About Us 
    - [The POCP Story](https://www.pocp.com/the-pocp-story/)
    - [Our Clients](https://www.pocp.com/our-client/) 
          - [Health & IT Vendors](https://www.pocp.com/our-client/health-it-vendors/)
          - [Payers & PBMS](https://www.pocp.com/our-client/payers-pbms/)
          - [Accountable Care](https://www.pocp.com/our-client/accountable-care/)
          - [Health Information Exchange](https://www.pocp.com/resource-library/health-information-exchange/)
    - [Our Team](https://www.pocp.com/our-team/)
    - [Government Contracting](https://info.pocp.com/gsa)
    - [Press](https://www.pocp.com/press/)
    - [Calendar](https://info.pocp.com/en-us/events)
    - [Careers at POCP](https://www.pocp.com/the-pocp-story/careers-at-pocp/)
- Insights 
    - [Articles and Industry Comments](https://www.pocp.com/articles/)
    - [Blog](https://blog.pocp.com/blog/)
    - [Newsletters HIT Perspectives](https://www.pocp.com/insight/newsletters-2/)
    - [Newsletters Biopharma](https://www.pocp.com/newsletters-biopharma/)
    - [POCP Industry Reports](https://www.pocp.com/industry-reports) 
          - [POCP Industry Reports](https://www.pocp.com/industry-reports)
          - [ePrior Authorization’s Real Benefits: Reducing Frictional Costs and Speeding Time to Therapy](https://www.pocp.com/downloads/ePAReport)
          - [Real-Time Pharmacy Benefit Check Report](https://www.pocp.com/pocp-industry-reports/real-time-pharmacy-benefit-check-report/)
          - [Fighting the Opioid Epidemic at the State- and Rx-Level Report](https://www.pocp.com/downloads/fighting-opioid-epidemic-at-rx-level-report)
          - [ePrescribing State Law On-Demand](https://www.pocp.com/downloads/eprescribing-state-law-on-demand/)
          - [State Law Review](https://www.pocp.com/statelawreview/)
          - [Navigator](https://www.pocp.com/navigator/)
    - [Podcasts](https://info.pocp.com/en-us/the-dish-on-health-it-podcast)
    - [Presentations and Webinars](https://www.pocp.com/presentations/)
    - [Resource Library](https://www.pocp.com/resource-library/)
    - [White Papers, Webinars and Case Studies](https://www.pocp.com/white-papers-webinars-and-case-studies-2/)
    - [Our video channel](https://www.pocp.com/our-video-channel)
- [Contact](https://www.pocp.com/contact/)

# Insights: Brief Points of View

# POCP Blog

---

## Da Vinci Project Poised for Accelerated Growth in Second Year

- December 18, 2018
- By [Jocelyn Keegan](https://blog.pocp.com/blog/author/jocelyn-keegan)
- [0 Comment](https://blog.pocp.com/blog/da_vinci_project_poised_to_grow#comments-listing)

Share this story:

![](https://blog.pocp.com/hs-fs/hubfs/Imported_Blog_Media/Da-Vinci-Less-Than-Two-Years-Graphic-1024x482.jpg?width=1024&height=482&name=Da-Vinci-Less-Than-Two-Years-Graphic-1024x482.jpg)  
 By [Jocelyn Keegan](https://www.pocp.com/team/jocelyn-keegan/), Point-of-Care Partners Payer Practice Lead and Da Vinci Program Manager

As 2018 draws to a close, the future is bright for the Da Vinci Project. Da Vinci is an industry-driven initiative to create a sustainable model of collaboration across competitors to remove barriers and unleash the bidirectional data necessary to fuel value-based care. The overarching goal is to improve appropriate clinical data sharing and metrics among providers and payers. Da Vinci leverages Health Level Seven's (HL7’s) FHIR (Fast Healthcare Interoperable Resource) platform.

**2018 Accomplishments.** We have made a lot progress this year, including:

- In January 2018, stakeholders approved the formation of Da Vinci and work began on the initial [use cases](http://www.hl7.org/about/davinci/use-cases.cfm). Currently, Da Vinci members are identifying payer/provider trading partners to develop and validate the artifacts and tools for two targeted use cases in 2018. 
    - [Data Exchange for Quality Measures (DEQM): aka Medication Reconciliation Post-Discharge (MRP)](http://www.hl7.org/about/davinci/use-cases.cfm)
    - [Coverage Requirements Discovery (CRD)](http://www.hl7.org/about/davinci/use-cases.cfm)
- In Summer 2018, the membership added two additional use cases: 
    - [Document Templates & Rules](http://www.hl7.org/about/davinci/use-cases.cfm) (DTR)
    - [eHealth Record Exchange in Support of HEDIS/STARS & Clinician Exchange (eHRx)](http://www.hl7.org/about/davinci/use-cases.cfm)
- In Fall 2018, the initial two use case Implementation Guides were balloted at HL7. Both Guides and Reference Implementation Materials are available on [confluence.hl7.org](http://confluence.hl7.org/).
- 27 organizations have joined Da Vinci so far. They include 12 payers, 3 vendors of electronic health records (EHRs); 10 vendors of health information technology products; and a growing number of providers. (Click [here](http://www.hl7.org/about/davinci/members.cfm) to see the individual members).
- Members have established a governance model that will ensure equal representation from stakeholders and offer transparency in order to make Da Vinci a sustainable model. On the business side, Da Vinci runs lean and smart. About two-thirds of membership dues go directly to project costs. Each staff member participating from member organizations averages 10-15 hours per week per project. In-kind space and support are provided by HL7, HIMSS and Optum Labs.

**What’s on deck for 2019?** In 2019, Da Vinci members plan to build on successes in 2018, continue to support existing FHIR versions, and adopt existing profiles where possible (Argonaut, US-Core, QI-Core). Upcoming activities include:

- Continue to drive members to test, pilot, and refine our first two use cases and ballot a second version of the Implementation Guides in May of 2019.
- Progress the work we have started on DTR and eHRx and take Implementation Guides to ballot in 2019.
- Prioritize and complete the initial work on up to four new potential use cases.

*Want to learn more? Please reach out to me, as Da Vinci Program Manager, at* ***[jocelyn.keegan@pocp.com](mailto:jocelyn.keegan%40pocp.com?subject=)****. You can also follow the Da Vinci page on* ***[HL7’s website (click here)](http://www.hl7.org/about/davinci/)****.*

- Post Categories
- [Value-Based Care](https://blog.pocp.com/blog/tag/value-based-care)
- [Da Vinci Project](https://blog.pocp.com/blog/tag/da-vinci-project)

# POCP Blog

---

Search

- There are no suggestions because the search field is empty.

### RECENT POSTS

### CATEGORIES

- [Interoperability (40)](https://blog.pocp.com/blog/tag/interoperability)
- [Health IT Policy (39)](https://blog.pocp.com/blog/tag/health-it-policy)
- [CMS (29)](https://blog.pocp.com/blog/tag/cms)
- [FHIR (25)](https://blog.pocp.com/blog/tag/fhir)
- [EHR (24)](https://blog.pocp.com/blog/tag/ehr)
- [Health IT Trends (20)](https://blog.pocp.com/blog/tag/health-it-trends)
- [ePrescribing (19)](https://blog.pocp.com/blog/tag/eprescribing)
- [Prior Authorization (17)](https://blog.pocp.com/blog/tag/prior-authorization)
- [Real-Time Benefit Check (15)](https://blog.pocp.com/blog/tag/real-time-benefit-check)
- [Real-Time Pharmacy Benefit Check (15)](https://blog.pocp.com/blog/tag/real-time-pharmacy-benefit-check)
- [Regulatory Trends (15)](https://blog.pocp.com/blog/tag/regulatory-trends)
- [APIs (14)](https://blog.pocp.com/blog/tag/apis)
- [Artificial Intelligence (13)](https://blog.pocp.com/blog/tag/artificial-intelligence)
- [Life Sciences (12)](https://blog.pocp.com/blog/tag/life-sciences)
- [electronic prior authorization (12)](https://blog.pocp.com/blog/tag/electronic-prior-authorization)
- [health IT (12)](https://blog.pocp.com/blog/tag/health-it)
- [NCPDP (10)](https://blog.pocp.com/blog/tag/ncpdp)
- [Policy (10)](https://blog.pocp.com/blog/tag/policy)
- [electronic health records (9)](https://blog.pocp.com/blog/tag/electronic-health-records)
- [pharmacy interoperability (9)](https://blog.pocp.com/blog/tag/pharmacy-interoperability)
- [ASTP (8)](https://blog.pocp.com/blog/tag/astp)
- [CMS NPRM (8)](https://blog.pocp.com/blog/tag/cms-nprm)
- [Payer (8)](https://blog.pocp.com/blog/tag/payer)
- [health information exchange (8)](https://blog.pocp.com/blog/tag/health-information-exchange)
- [HL7 (7)](https://blog.pocp.com/blog/tag/hl7)
- [Specialty Pharmacy (7)](https://blog.pocp.com/blog/tag/specialty-pharmacy)
- [Standards Development (7)](https://blog.pocp.com/blog/tag/standards-development)
- [TEFCA (7)](https://blog.pocp.com/blog/tag/tefca)
- [Value-Based Care (7)](https://blog.pocp.com/blog/tag/value-based-care)
- [e-Prescribing (7)](https://blog.pocp.com/blog/tag/e-prescribing)
- [electronic prescribing (7)](https://blog.pocp.com/blog/tag/electronic-prescribing)
- [Da Vinci Project (6)](https://blog.pocp.com/blog/tag/da-vinci-project)
- [Federal Healthcare Policy (6)](https://blog.pocp.com/blog/tag/federal-healthcare-policy)
- [HHS (6)](https://blog.pocp.com/blog/tag/hhs)
- [HTI-2 (6)](https://blog.pocp.com/blog/tag/hti-2)
- [ONC (6)](https://blog.pocp.com/blog/tag/onc)
- [Payer Interoperability (6)](https://blog.pocp.com/blog/tag/payer-interoperability)
- [Strategy and Research (6)](https://blog.pocp.com/blog/tag/strategy-and-research)
- [healthcare reform (6)](https://blog.pocp.com/blog/tag/healthcare-reform)
- [pharmaceutical marketing (6)](https://blog.pocp.com/blog/tag/pharmaceutical-marketing)
- [21st Century Cures Act (5)](https://blog.pocp.com/blog/tag/21st-century-cures-act)
- [Consent (5)](https://blog.pocp.com/blog/tag/consent)
- [EHR Usability (5)](https://blog.pocp.com/blog/tag/ehr-usability)
- [EPCS (5)](https://blog.pocp.com/blog/tag/epcs)
- [Health Plans (5)](https://blog.pocp.com/blog/tag/health-plans)
- [Health Technology Solutions (5)](https://blog.pocp.com/blog/tag/health-technology-solutions)
- [Information Blocking (5)](https://blog.pocp.com/blog/tag/information-blocking)
- [NCPDP SCRIPT (5)](https://blog.pocp.com/blog/tag/ncpdp-script)
- [Patient Data (5)](https://blog.pocp.com/blog/tag/patient-data)
- [Pharmacy (5)](https://blog.pocp.com/blog/tag/pharmacy)
- [Strategic roadmap (5)](https://blog.pocp.com/blog/tag/strategic-roadmap)
- [health equity (5)](https://blog.pocp.com/blog/tag/health-equity)
- [population health (5)](https://blog.pocp.com/blog/tag/population-health)
- [Clinical Decision Support (4)](https://blog.pocp.com/blog/tag/cds)
- [Digital Health Programs (4)](https://blog.pocp.com/blog/tag/digital-health-programs)
- [Digital Therapeutics (4)](https://blog.pocp.com/blog/tag/digital-therapeutics)
- [EHR Dashboard (4)](https://blog.pocp.com/blog/tag/ehr-dashboard)
- [HIE (4)](https://blog.pocp.com/blog/tag/hie)
- [Healthcare AI (4)](https://blog.pocp.com/blog/tag/healthcare-ai)
- [Meaningful Use (4)](https://blog.pocp.com/blog/tag/meaningful-use)
- [PDMP (4)](https://blog.pocp.com/blog/tag/pdmp)
- [Pharmaceutical Manufacturers (4)](https://blog.pocp.com/blog/tag/pharmaceutical-manufacturers)
- [Pharmacy Benefit Management (4)](https://blog.pocp.com/blog/tag/pharmacy-benefit-management)
- [burden reduction (4)](https://blog.pocp.com/blog/tag/burden-reduction)
- [ePrior Authorization (4)](https://blog.pocp.com/blog/tag/eprior-authorization)
- [healthcare regulations (4)](https://blog.pocp.com/blog/tag/healthcare-regulations)
- [pharmacy advance practice (4)](https://blog.pocp.com/blog/tag/pharmacy-advance-practice)
- [price transparency (4)](https://blog.pocp.com/blog/tag/price-transparency)
- [Administrative Burden (3)](https://blog.pocp.com/blog/tag/administrative-burden)
- [COVID-19 (3)](https://blog.pocp.com/blog/tag/covid-19)
- [Clinical Calculators (3)](https://blog.pocp.com/blog/tag/clinical-calculators)
- [Data Governance (3)](https://blog.pocp.com/blog/tag/data-governance)
- [Diabetes Care (3)](https://blog.pocp.com/blog/tag/diabetes-care)
- [Digital Health (3)](https://blog.pocp.com/blog/tag/digital-health)
- [Drug price transparency (3)](https://blog.pocp.com/blog/tag/drug-price-transparency)
- [EHR Guides (3)](https://blog.pocp.com/blog/tag/ehr-guides)
- [EHR Reports (3)](https://blog.pocp.com/blog/tag/ehr-reports)
- [EHRs (3)](https://blog.pocp.com/blog/tag/ehrs)
- [HIMSS (3)](https://blog.pocp.com/blog/tag/himss)
- [Implementation (3)](https://blog.pocp.com/blog/tag/implementation)
- [Innovation (3)](https://blog.pocp.com/blog/tag/innovation)
- [Medication Therapy Management (3)](https://blog.pocp.com/blog/tag/mtm)
- [National Patient Identifier (3)](https://blog.pocp.com/blog/tag/national-patient-identifier)
- [Patient Safety (3)](https://blog.pocp.com/blog/tag/patient-safety)
- [Pharmacy Benefit (3)](https://blog.pocp.com/blog/tag/pharmacy-benefit)
- [Request for Information (3)](https://blog.pocp.com/blog/tag/request-for-information)
- [Speed to Therapy (3)](https://blog.pocp.com/blog/tag/speed-to-therapy)
- [patient access (3)](https://blog.pocp.com/blog/tag/patient-access)
- [state prescribing laws (3)](https://blog.pocp.com/blog/tag/state-prescribing-laws)
- [AI Policy (2)](https://blog.pocp.com/blog/tag/ai-policy)
- [CDC (2)](https://blog.pocp.com/blog/tag/cdc)
- [CMS-0062P (2)](https://blog.pocp.com/blog/tag/cms-0062p)
- [Centers for Disease Control (2)](https://blog.pocp.com/blog/tag/centers-for-disease-control)
- [Controlled Substances (2)](https://blog.pocp.com/blog/tag/controlled-substances)
- [Data Efficiency (2)](https://blog.pocp.com/blog/tag/data-efficiency)
- [EHR Certification (2)](https://blog.pocp.com/blog/tag/ehr-certification)
- [Epic (2)](https://blog.pocp.com/blog/tag/epic)
- [FDA (2)](https://blog.pocp.com/blog/tag/fda)
- [Formulary and Benefit (2)](https://blog.pocp.com/blog/tag/formulary-and-benefit)
- [H.R. 6 (2)](https://blog.pocp.com/blog/tag/h-r-6)
- [Market Assessment (2)](https://blog.pocp.com/blog/tag/market-assessment)
- [Medical Benefit (2)](https://blog.pocp.com/blog/tag/medical-benefit)
- [Medical Pharmacy Benefit Integration (2)](https://blog.pocp.com/blog/tag/medical-pharmacy-benefit-integration)
- [Medicare Payment Reform (2)](https://blog.pocp.com/blog/tag/medicare-payment-reform)
- [Medication Adherence (2)](https://blog.pocp.com/blog/tag/medication-adherence)
- [Member Data (2)](https://blog.pocp.com/blog/tag/member-data)
- [NCPDP Telecommunications Standard Version F6 (2)](https://blog.pocp.com/blog/tag/ncpdp-telecommunications-standard-version-f6)
- [ONC Physician Burden Reduction (2)](https://blog.pocp.com/blog/tag/onc-physician-burden-reduction)
- [Opioid prescribing laws (2)](https://blog.pocp.com/blog/tag/opioid-prescribing-laws)
- [PGx (2)](https://blog.pocp.com/blog/tag/pgx)
- [Part D (2)](https://blog.pocp.com/blog/tag/part-d)
- [Patient Record Sharing (2)](https://blog.pocp.com/blog/tag/patient-record-sharing)
- [Policy monitoring (2)](https://blog.pocp.com/blog/tag/policy-monitoring)
- [Pre-approval Information Exchange (2)](https://blog.pocp.com/blog/tag/pre-approval-information-exchange)
- [Precision Medicine (2)](https://blog.pocp.com/blog/tag/precision-medicine)
- [REMS (2)](https://blog.pocp.com/blog/tag/rems)
- [Regulatory landscape (2)](https://blog.pocp.com/blog/tag/regulatory-landscape)
- [Specialty Pharmacy Automation (2)](https://blog.pocp.com/blog/tag/specialty-pharmacy-automation)
- [Specialty ePrescribing (2)](https://blog.pocp.com/blog/tag/specialty-eprescribing)
- [Speed to Medication Therapy (2)](https://blog.pocp.com/blog/tag/speed-to-medication-therapy)
- [Telehealth (2)](https://blog.pocp.com/blog/tag/telehealth)
- [Telemedicine (2)](https://blog.pocp.com/blog/tag/telemedicine)
- [care coordination (2)](https://blog.pocp.com/blog/tag/care-coordination)
- [compliance (2)](https://blog.pocp.com/blog/tag/compliance)
- [ePA (2)](https://blog.pocp.com/blog/tag/epa)
- [eRx (2)](https://blog.pocp.com/blog/tag/erx)
- [health dashboards (2)](https://blog.pocp.com/blog/tag/health-dashboards)
- [medication management (2)](https://blog.pocp.com/blog/tag/medication-management)
- [opioid abuse (2)](https://blog.pocp.com/blog/tag/opioid-abuse)
- [pharmacist (2)](https://blog.pocp.com/blog/tag/pharmacist)
- [pharmacy business model (2)](https://blog.pocp.com/blog/tag/pharmacy-business-model)
- [prior authorizations (2)](https://blog.pocp.com/blog/tag/prior-authorizations)
- [wearables (2)](https://blog.pocp.com/blog/tag/wearables)
- [ACO (1)](https://blog.pocp.com/blog/tag/aco)
- [AI in Healthcare (1)](https://blog.pocp.com/blog/tag/ai-in-healthcare)
- [Antikickback Statutes Reform (1)](https://blog.pocp.com/blog/tag/antikickback-statutes-reform)
- [Biologics and Biosimilars Naming (1)](https://blog.pocp.com/blog/tag/biologics-and-biosimilars-naming)
- [Biosimilars (1)](https://blog.pocp.com/blog/tag/biosimilars)
- [Business Process (1)](https://blog.pocp.com/blog/tag/business-process)
- [CAQH Phase V Operating Rules (1)](https://blog.pocp.com/blog/tag/caqh-phase-v-operating-rules)
- [CARIN Alliance (1)](https://blog.pocp.com/blog/tag/carin-alliance)
- [CDS Hooks (1)](https://blog.pocp.com/blog/tag/cds-hooks)
- [CMS Attachments Rule (1)](https://blog.pocp.com/blog/tag/cms-attachments-rule)
- [CRD (1)](https://blog.pocp.com/blog/tag/crd)
- [Canada Biosimilars Naming (1)](https://blog.pocp.com/blog/tag/canada-biosimilars-naming)
- [Canadian ePrescribing (1)](https://blog.pocp.com/blog/tag/canadian-eprescribing)
- [Chronic Disease (1)](https://blog.pocp.com/blog/tag/chronic-disease)
- [Clinical Quality Language (CQL) (1)](https://blog.pocp.com/blog/tag/clinical-quality-language-cql)
- [CodeX (1)](https://blog.pocp.com/blog/tag/codex)
- [CoverMyMeds (1)](https://blog.pocp.com/blog/tag/covermymeds)
- [DSMO (1)](https://blog.pocp.com/blog/tag/dsmo)
- [DTR (1)](https://blog.pocp.com/blog/tag/dtr)
- [DTx (1)](https://blog.pocp.com/blog/tag/dtx)
- [Data Modernization Initiative (1)](https://blog.pocp.com/blog/tag/data-modernization-initiative)
- [Data quality (1)](https://blog.pocp.com/blog/tag/data-quality)
- [Designated Standards Maintenance Organizations (1)](https://blog.pocp.com/blog/tag/designated-standards-maintenance-organizations)
- [Digital Therapeutics Opportunities (1)](https://blog.pocp.com/blog/tag/digital-therapeutics-opportunities)
- [Digital Therapeutics Outlook (1)](https://blog.pocp.com/blog/tag/digital-therapeutics-outlook)
- [Discover Alliance (1)](https://blog.pocp.com/blog/tag/discover-alliance)
- [Drug Launch (1)](https://blog.pocp.com/blog/tag/drug-launch)
- [Drug Manufacturers (1)](https://blog.pocp.com/blog/tag/drug-manufacturers)
- [Drug PA (1)](https://blog.pocp.com/blog/tag/drug-pa)
- [Drug abuse (1)](https://blog.pocp.com/blog/tag/drug-abuse)
- [EHR Apps (1)](https://blog.pocp.com/blog/tag/ehr-apps)
- [Enforcement (1)](https://blog.pocp.com/blog/tag/enforcement)
- [FQHC (1)](https://blog.pocp.com/blog/tag/fqhc)
- [Federally Qualified Health Centers (1)](https://blog.pocp.com/blog/tag/federally-qualified-health-centers)
- [Fee-for-service (1)](https://blog.pocp.com/blog/tag/fee-for-service)
- [Gold-carding (1)](https://blog.pocp.com/blog/tag/gold-carding)
- [HIN (1)](https://blog.pocp.com/blog/tag/hin)
- [HIPAA (1)](https://blog.pocp.com/blog/tag/hipaa)
- [HIT Leaders (1)](https://blog.pocp.com/blog/tag/hit-leaders)
- [HTI-4 (1)](https://blog.pocp.com/blog/tag/hti-4)
- [Health and Human Services (1)](https://blog.pocp.com/blog/tag/health-and-human-services)
- [Health data (1)](https://blog.pocp.com/blog/tag/health-data)
- [Health system (1)](https://blog.pocp.com/blog/tag/health-system)
- [Healthcare artificial intelligence trends (1)](https://blog.pocp.com/blog/tag/healthcare-artificial-intelligence-trends)
- [Human Services (1)](https://blog.pocp.com/blog/tag/human-services)
- [Hypertension (1)](https://blog.pocp.com/blog/tag/hypertension)
- [I-STOP (1)](https://blog.pocp.com/blog/tag/i-stop)
- [Insurance (1)](https://blog.pocp.com/blog/tag/insurance)
- [Landscape analysis (1)](https://blog.pocp.com/blog/tag/landscape-analysis)
- [MACRA (1)](https://blog.pocp.com/blog/tag/macra)
- [MIPS (1)](https://blog.pocp.com/blog/tag/mips)
- [Market Intelligence (1)](https://blog.pocp.com/blog/tag/market-intelligence)
- [Market Research (1)](https://blog.pocp.com/blog/tag/market-research)
- [Medication Therapy Management (1)](https://blog.pocp.com/blog/tag/medication-therapy-management)
- [Modernizing Part D CMS-4180-P (1)](https://blog.pocp.com/blog/tag/modernizing-part-d-cms-4180-p)
- [NCPDP F&B (1)](https://blog.pocp.com/blog/tag/ncpdp-fb)
- [NCPDP SCRIPT 2017071 (1)](https://blog.pocp.com/blog/tag/ncpdp-script-2017071)
- [NCPDP Workgroups (1)](https://blog.pocp.com/blog/tag/ncpdp-workgroups)
- [NCQA (1)](https://blog.pocp.com/blog/tag/ncqa)
- [NDC (1)](https://blog.pocp.com/blog/tag/ndc)
- [NPI (1)](https://blog.pocp.com/blog/tag/npi)
- [Objective Analysis (1)](https://blog.pocp.com/blog/tag/objective-analysis)
- [Outcomes (1)](https://blog.pocp.com/blog/tag/outcomes)
- [P2 FHIR Taskforce (1)](https://blog.pocp.com/blog/tag/p2-fhir-taskforce)
- [PAS (1)](https://blog.pocp.com/blog/tag/pas)
- [PBMs (1)](https://blog.pocp.com/blog/tag/pbms)
- [PIE (1)](https://blog.pocp.com/blog/tag/pie)
- [POCP News (1)](https://blog.pocp.com/blog/tag/pocp-news)
- [Pain Management (1)](https://blog.pocp.com/blog/tag/pain-management)
- [Payer to Payer (1)](https://blog.pocp.com/blog/tag/payer-to-payer)
- [Pharmacogenomics (1)](https://blog.pocp.com/blog/tag/pharmacogenomics)
- [Point-of-Care (1)](https://blog.pocp.com/blog/tag/point-of-care)
- [Population Health Management (1)](https://blog.pocp.com/blog/tag/population-health-management)
- [Prescribing Authority (1)](https://blog.pocp.com/blog/tag/prescribing-authority)
- [Prescribing signatures (1)](https://blog.pocp.com/blog/tag/prescribing-signatures)
- [Prescription Price Transparency (1)](https://blog.pocp.com/blog/tag/prescription-price-transparency)
- [Prescription affordability (1)](https://blog.pocp.com/blog/tag/prescription-affordability)
- [Prescription drug benefit (1)](https://blog.pocp.com/blog/tag/prescription-drug-benefit)
- [Prescription pricing (1)](https://blog.pocp.com/blog/tag/prescription-pricing)
- [Public Health (1)](https://blog.pocp.com/blog/tag/public-health)
- [Quality Measures (1)](https://blog.pocp.com/blog/tag/quality-measures)
- [Quality Reporting (1)](https://blog.pocp.com/blog/tag/quality-reporting)
- [RTBT (1)](https://blog.pocp.com/blog/tag/rtbt)
- [RTPB (1)](https://blog.pocp.com/blog/tag/rtpb)
- [Regulatory overhead (1)](https://blog.pocp.com/blog/tag/regulatory-overhead)
- [RelayHealth (1)](https://blog.pocp.com/blog/tag/relayhealth)
- [Rx renewal (1)](https://blog.pocp.com/blog/tag/rx-renewal)
- [RxBC (1)](https://blog.pocp.com/blog/tag/rxbc)
- [Sandbox (1)](https://blog.pocp.com/blog/tag/sandbox)
- [Social Determinants of Health (1)](https://blog.pocp.com/blog/tag/social-determinants-of-health)
- [Specialty Pharmacy Enrollment (1)](https://blog.pocp.com/blog/tag/specialty-pharmacy-enrollment)
- [Specialty medication (1)](https://blog.pocp.com/blog/tag/specialty-medication)
- [Stark Anti-Kickback Statute (1)](https://blog.pocp.com/blog/tag/stark-anti-kickback-statute)
- [Stark Law Reform (1)](https://blog.pocp.com/blog/tag/stark-law-reform)
- [State policy (1)](https://blog.pocp.com/blog/tag/state-policy)
- [Surescripts (1)](https://blog.pocp.com/blog/tag/surescripts)
- [Telecommunications (1)](https://blog.pocp.com/blog/tag/telecommunications)
- [Telehealth / Telemedicine (1)](https://blog.pocp.com/blog/tag/telehealth-telemedicine)
- [U.S. Senate Special Committee on Aging (1)](https://blog.pocp.com/blog/tag/u-s-senate-special-committee-on-aging)
- [Uncategorized (1)](https://blog.pocp.com/blog/tag/uncategorized)
- [Virtual Visits (1)](https://blog.pocp.com/blog/tag/virtual-visits)
- [Working from home (1)](https://blog.pocp.com/blog/tag/working-from-home)
- [X12 (1)](https://blog.pocp.com/blog/tag/x12)
- [ambient listening (1)](https://blog.pocp.com/blog/tag/ambient-listening)
- [blockchain (1)](https://blog.pocp.com/blog/tag/blockchain)
- [care gaps (1)](https://blog.pocp.com/blog/tag/care-gaps)
- [cms-0057 (1)](https://blog.pocp.com/blog/tag/cms-0057)
- [community pharmacy (1)](https://blog.pocp.com/blog/tag/community-pharmacy)
- [consumerism (1)](https://blog.pocp.com/blog/tag/consumerism)
- [data platforms (1)](https://blog.pocp.com/blog/tag/data-platforms)
- [digiceuticals (1)](https://blog.pocp.com/blog/tag/digiceuticals)
- [digital health platforms (1)](https://blog.pocp.com/blog/tag/digital-health-platforms)
- [eConsent (1)](https://blog.pocp.com/blog/tag/econsent)
- [eMedication Management (1)](https://blog.pocp.com/blog/tag/emedication-management)
- [healthcare (1)](https://blog.pocp.com/blog/tag/healthcare)
- [home health (1)](https://blog.pocp.com/blog/tag/home-health)
- [machine learning (1)](https://blog.pocp.com/blog/tag/machine-learning)
- [medical deserts (1)](https://blog.pocp.com/blog/tag/medical-deserts)
- [patient generated data (1)](https://blog.pocp.com/blog/tag/patient-generated-data)
- [payers (1)](https://blog.pocp.com/blog/tag/payers)
- [payment model (1)](https://blog.pocp.com/blog/tag/payment-model)
- [prescription drug monitoring programs (1)](https://blog.pocp.com/blog/tag/prescription-drug-monitoring-programs)
- [rural health (1)](https://blog.pocp.com/blog/tag/rural-health)
- [vive (1)](https://blog.pocp.com/blog/tag/vive)

See all

[![Point-of-Care Partners](https://blog.pocp.com/hubfs/PointOfCarePartners_January2020/images/pocp-web-retina-logo-footer.jpg "Point-of-Care Partners")](https://www.pocp.com)

©2026 Point-of-Care Partners | All Rights Reserved

- [![Twitter](https://blog.pocp.com/hubfs/PointOfCarePartners_January2020/images/Twitter-icon.png "Twitter")](https://twitter.com/pocpHIT)
- [![LinkedIn](https://blog.pocp.com/hubfs/PointOfCarePartners_January2020/images/linkedin-icon.png "LinkedIn")](http://www.linkedin.com/company/point-of-care-partners)
- [![RSS](https://blog.pocp.com/hubfs/PointOfCarePartners_January2020/images/rss-icon.png "RSS")](https://www.pocp.com/pocp-blog/)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Jocelyn Keegan",
    "url" : "https://blog.pocp.com/blog/author/jocelyn-keegan"
  },
  "dateModified" : "2020-06-19T15:25:58.200Z",
  "datePublished" : "2018-12-18T18:24:05.000Z",
  "headline" : "Da Vinci Project Poised for Accelerated Growth in Second Year",
  "image" : [ "https://blog.pocp.com/hubfs/Imported_Blog_Media/Da-Vinci-Less-Than-Two-Years-Graphic-1024x482.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://blog.pocp.com/blog/da_vinci_project_poised_to_grow",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://blog.pocp.com/hubfs/pocp-logo-2016.jpg"
    },
    "name" : "Point-of-Care Partners"
  }
}
```